Company Overview
| Stock Name | Beautyfarm Med |
|---|---|
| Stock Code | 02373 |
| Company Full Name | To be extracted |
| Industry | 醫療保健 |
| Principal Activities | 公司是中國最大的傳統美容服務提供商和第四大的非外科手術類醫療美容服務提供商。 |
| Listing Date | 2023-01-16 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國上海市虹口區東大名路1089號12層1206單元 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://www.beautyfarm.com.cn/ |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 19.32 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 53.5% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 234,950,520 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
Pool A
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 500 | HK$ 9,660 |
| 2 lots | 1,000 | HK$ 19,320 |
| 3 lots | 1,500 | HK$ 28,980 |
| 4 lots | 2,000 | HK$ 38,640 |
| 5 lots | 2,500 | HK$ 48,300 |
| 6 lots | 3,000 | HK$ 57,960 |
| 7 lots | 3,500 | HK$ 67,620 |
| 8 lots | 4,000 | HK$ 77,280 |
| 9 lots | 4,500 | HK$ 86,940 |
| 10 lots | 5,000 | HK$ 96,600 |
| 12 lots | 6,000 | HK$ 115,920 |
| 14 lots | 7,000 | HK$ 135,240 |
| 16 lots | 8,000 | HK$ 154,560 |
| 18 lots | 9,000 | HK$ 173,880 |
| 20 lots | 10,000 | HK$ 193,200 |
| 30 lots | 15,000 | HK$ 289,800 |
| 40 lots | 20,000 | HK$ 386,400 |
| 50 lots | 25,000 | HK$ 483,000 |
| 60 lots | 30,000 | HK$ 579,600 |
| 70 lots | 35,000 | HK$ 676,200 |
| 80 lots | 40,000 | HK$ 772,800 |
| 90 lots | 45,000 | HK$ 869,400 |
| 100 lots | 50,000 | HK$ 966,000 |
| 120 lots | 60,000 | HK$ 1,159,200 |
| 140 lots | 70,000 | HK$ 1,352,400 |
| 160 lots | 80,000 | HK$ 1,545,600 |
| 180 lots | 90,000 | HK$ 1,738,800 |
| 200 lots | 100,000 | HK$ 1,932,000 |
| 300 lots | 150,000 | HK$ 2,898,000 |
| 400 lots | 200,000 | HK$ 3,864,000 |
| 500 lots | 250,000 | HK$ 4,830,000 |
Pool B
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 600 lots | 300,000 | HK$ 5,796,000 |
| 700 lots | 350,000 | HK$ 6,762,000 |
| 800 lots | 400,000 | HK$ 7,728,000 |
| 900 lots | 450,000 | HK$ 8,694,000 |
| 1,000 lots | 500,000 | HK$ 9,660,000 |
| 1,200 lots | 600,000 | HK$ 11,592,000 |
| 1,400 lots | 700,000 | HK$ 13,524,000 |
| 3,000 lots | 1,500,000 | HK$ 28,980,000 |
| 4,054 lots | 2,027,000 | HK$ 39,161,640 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | None |
|---|---|
| HK Market Cap | --- |
| Est. Threshold | --- |
| Analysis Result | 无法确定入通路径 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
| First Day Close | HK$ 29.65 |
|---|---|
| First Day Open | HK$ 30.5 |
| First Day Change | 53.47% |
| First Day Volume | 15236000.0 |
| First Day Turnover | 450434000.0 |
| Use of Proceeds | 1、67.6%或約261.7百萬港元將分配至擴張及升級我們的服務網絡；
2、10.2%或約39.5百萬港元將用于進行戰略并購加盟店；
3、12.3%或約47.6百萬港元將分配至進一步投資于我們的信息技術系統；
4、9.9%或約38.4百萬港元將分配至營運資金及其他一般企業用途。 |
Underwriting Syndicate
Joint Sponsors (3)
Overall Coordinators (3)
Joint Bookrunners (5)
Joint Lead Managers (8)
Morgan Stanley Asia Limited CE AAD291
海通国际证券有限公司 CE AAF806
HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809
CLSA LIMITED CE AAB893
ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299
TIGER BROKERS (HK) GLOBAL LIMITED CE BMU940
Futu Securities International (HONG KONG) Limited CE AZT137
VALUABLE CAPITAL LIMITED CE AUL711
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Harvest International Premium Value (Secondary Market) Fund SPC | 155,603,280 HKD | — | 19.87% | — | 6 months | 2023-07-16 |
| 2 | Juzi Holding Co., Ltd | 77,801,640 HKD | — | 9.93% | — | 6 months | 2023-07-16 |
| 3 | TruMed | 131,327,700 HKD | — | 16.77% | — | 6 months | 2023-07-16 |
| 4 | 昆明贝泰妮生物科技销售有限公司 | 54,453,420 HKD | — | 6.95% | — | 6 months | 2023-07-16 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 李陽 | — |
| Company Secretary | 周敏;郭兆瑩 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Beijing Xinyu Meiye Holdings Limited(25.13%);LIFY Management Holdings Limited(18.39%);LIY Management Holdings Limited(15.42%);MeiYao Holdings Limited(15.19%) |
|---|
